spironolactone has been researched along with pioglitazone in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 11 (47.83) | 24.3611 |
| 2020's | 10 (43.48) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Simorre, B | 1 |
| Asaumi, N; Kumagai, K; Mitamura, Y; Oshitari, T; Watanabe, M | 1 |
| Chang, CS; Chen, JY; Ho, LC; Maeda, N; Pandya, K; Sung, JM; Tsai, PJ; Tsai, YS | 1 |
| Chen, W; Fu, C; Lu, Y; Xiao, J; Yan, Z; Ye, Z; Zhang, X; Zhang, Z | 1 |
| Al Khalifah, RA; Bassilious, E; Dennis, B; Flórez, ID; Neupane, B; Thabane, L | 1 |
| de Zegher, F; Del Río, L; Díaz, M; Ibáñez, L; López-Bermejo, A; Pozo, ÓJ; Sebastiani, G | 1 |
| Damle, L; Gomez-Lobo, V; Sullivan, S; Uliassi, N | 1 |
| de Zegher, F; Garcia-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Sánchez-Infantes, D; Taxerås, SD | 1 |
| de Zegher, F; Ibáñez, L | 1 |
| Bassols, J; de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A | 1 |
| Liu, YT; Long, SL; Mo, ZC; Xie, YJ; Zeng, X | 1 |
| Bhat, GA; Ganie, MA; Rashid, A; Shah, ZA; Shaheen, F; Shrivastava, M; Wani, IA | 1 |
| Cereijo, R; de Zegher, F; García-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Quesada-López, T; Villarroya, F | 1 |
| Brotons, P; Carbonetto, B; de Zegher, F; Garcia-Beltran, C; González-Torres, P; Henares, D; Ibáñez, L; López-Bermejo, A; Malpique, R; Muñoz-Almagro, C | 1 |
| Cairó, M; de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Villarroya, F; Villarroya, J | 1 |
| Dehghan, Z; Mirmotalebisohi, SA; Mohammadi-Yeganeh, S; Salehi, M; Sameni, M; Zali, H | 1 |
| Bassols, J; Carreras-Badosa, G; de Zegher, F; Garcia-Beltran, C; Ibáñez, L; López Bermejo, A | 1 |
| Andersen, MS; Bas, F; Bassols, J; Darendeliler, F; de Zegher, F; Díaz, M; Dieris, B; Fanelli, F; Fröhlich-Reiterer, E; Gambineri, A; Garcia-Beltran, C; Glintborg, D; Ibáñez, L; López-Bermejo, A; Malpique, R; Mann, C; Marin, S; Obermayer-Pietsch, B; Ravn, P; Reinehr, T; Renzulli, M; Salvador, C; Singer, V; Torres, JV; Vanky, E; Yildiz, M; Ødegård, R | 1 |
3 review(s) available for spironolactone and pioglitazone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol.
Topics: Adolescent; Androgen Antagonists; Contraceptives, Oral; Diet; Drug Therapy, Combination; Exercise; Female; Flutamide; Humans; Hypoglycemic Agents; Life Style; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Research Design; Spironolactone; Systematic Reviews as Topic; Thiazolidinediones; Young Adult | 2015 |
Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
Topics: Androgens; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone | 2020 |
7 trial(s) available for spironolactone and pioglitazone
| Article | Year |
|---|---|
Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.
Topics: Adolescent; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Intra-Abdominal Fat; Levonorgestrel; Metformin; Oligomenorrhea; Ovulation; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Thiazolidinediones | 2017 |
Towards a circulating marker of hepato-visceral fat excess: S100A4 in adolescent girls with polycystic ovary syndrome - Evidence from randomized clinical trials.
Topics: Adolescent; Adult; Biomarkers; Body Mass Index; Contraceptives, Oral; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Intra-Abdominal Fat; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; S100 Calcium-Binding Protein A4; Spironolactone | 2019 |
Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments.
Topics: Adolescent; Biomarkers; Contraceptives, Oral; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Metformin; MicroRNAs; Pilot Projects; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome | 2020 |
Differential Impact of Insulin Sensitizers vs. Anti-Androgen on Serum Leptin Levels in Vitamin D Replete PCOS Women: A Six Month Open Labeled Randomized Study.
Topics: Adult; Blood Glucose; Female; Humans; Insulin; Insulin Resistance; Leptin; Metformin; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Testosterone; Vitamin D; Young Adult | 2020 |
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome | 2020 |
The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat.
Topics: Adolescent; Adult; Case-Control Studies; Child; Fatty Liver; Female; Growth Differentiation Factor 15; Humans; Hypoglycemic Agents; Male; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Young Adult | 2021 |
SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a mult
Topics: Adolescent; Carotid Intima-Media Thickness; Clinical Trials, Phase II as Topic; Female; Humans; Insulin; Life Style; Metformin; Multicenter Studies as Topic; Pioglitazone; Polycystic Ovary Syndrome; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone; Young Adult | 2023 |
13 other study(ies) available for spironolactone and pioglitazone
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
[41th Congress of EASD (European Association for The Study of Diabetes) 10 to 15 September 2005, Athens, Greece].
Topics: Aged; Albuminuria; Antihypertensive Agents; Bone Density Conservation Agents; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Multicenter Studies as Topic; Pioglitazone; Prospective Studies; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Spironolactone; Thiazolidinediones; Time Factors | 2006 |
Severe macular edema induced by pioglitazone in a patient with diabetic retinopathy: a case study.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diuretics; Female; Fluorescein Angiography; Humans; Hypoglycemic Agents; Light Coagulation; Macular Edema; Pioglitazone; Severity of Illness Index; Spironolactone; Thiazolidinediones; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2008 |
Diuretics prevent thiazolidinedione-induced cardiac hypertrophy without compromising insulin-sensitizing effects in mice.
Topics: Animals; Cardiac Volume; Cardiomegaly; Diuretics; Extracellular Signal-Regulated MAP Kinases; Furosemide; Gene Expression Regulation; Glucose; Insulin; Lipid Metabolism; Mice; Mice, Inbred C57BL; Pioglitazone; PPAR gamma; Rosiglitazone; Signal Transduction; Spironolactone; Thiazolidinediones; Trichlormethiazide; Ultrasonography | 2014 |
Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
Topics: Anilides; Anti-Inflammatory Agents; Cell Line; Drug Synergism; Eplerenone; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Kidney Tubules, Proximal; Mineralocorticoid Receptor Antagonists; NF-kappa B; Pioglitazone; PPAR gamma; Receptors, Mineralocorticoid; Spironolactone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
Trends, in Diagnosis and Treatment of Polycystic Ovarian Syndrome by Specialty.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Diagnostic Tests, Routine; Diuretics; Endocrinologists; Female; General Practitioners; Gynecology; Humans; Hydrocortisone; Hypoglycemic Agents; Life Style; Lipids; Metformin; Pioglitazone; Polycystic Ovary Syndrome; Practice Patterns, Physicians'; Retrospective Studies; Spironolactone; Young Adult | 2016 |
Polycystic ovary syndrome in adolescent girls.
Topics: Adolescent; Female; Humans; Metformin; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone | 2020 |
Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments.
Topics: Adolescent; Female; Gastrointestinal Microbiome; Humans; Metformin; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone | 2021 |
Repurposing new drug candidates and identifying crucial molecules underlying PCOS Pathogenesis Based On Bioinformatics Analysis.
Topics: Computational Biology; Databases, Protein; Drug Repositioning; Female; Gene Expression Regulation; Humans; Letrozole; Metformin; Phosphatidylinositol 3-Kinases; Pioglitazone; Polycystic Ovary Syndrome; Protein Interaction Maps; Proteomics; Proto-Oncogene Proteins c-akt; Signal Transduction; Spironolactone | 2021 |
Raised Thyroid-Stimulating Hormone in Girls with Polycystic Ovary Syndrome: Effects of Randomized Interventions.
Topics: Adolescent; Female; Humans; Metformin; Pioglitazone; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Spironolactone; Thyrotropin | 2023 |